Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1632 results

Fractional flow reserve to guide revascularisation in patients with coronary artery disease undergoing TAVR

07 Jan 2026

The present analysis compared major adverse cardiac events in patients with significant coronary stenosis (FFR ≤ 0.80 or visual stenosis ≥ 90 %) versus those with non-significant stenosis (FFR > 0.80).

Ruxandra Sava

Reviewer

Ruxandra Sava
Alessandro Sticchi

Reviewer

Alessandro Sticchi
Fractional flow reserve to guide revascularisation in patients with coronary artery disease undergoing TAVR

How to manage Safari wire entrapment during TAVI with Navitor THV

06 Jan 2026

Safari wire entrapment during TAVI is a rare but potentially serious complication, particularly with sheathless self-expanding valves. In this My Toolkit article, we describe a simple, effective technique using a parallel stiff guidewire to safely retrieve both the catheter and the entrapped Safari wire when performing...

Mauro Boiago

Author

Mauro Boiago
Neila Sayah

Author

Neila Sayah
Stéphane Champagne

Author

Stéphane Champagne

Author

Antoinette Neylon
How to manage Safari wire entrapment during TAVI with Navitor THV

When a surgical valve needs a second life

23 Dec 2025

A 79-year-old patient previously treated with surgical aortic valve replacement was referred after an episode of acute cardiac decompensation. Although clinically stabilised, further evaluation revealed degeneration of the bioprosthesis, and mixed aortic valve pathology.

This case focuses on the diagnostic assessment and the strategic considerations guiding the...

Christina Grothusen

Author

Christina Grothusen
When a surgical valve needs a second life

Overcoming complexity in TAVI: a patient-centered approach

19 Dec 2025

Register for free to this webinar on Monday 12 January at 5:00pm (UTC+1) with H. Mölmann, R. Hahn, W-K. Kim and P. Lauten, and discuss different sources of complexity in TAVI and much more!

Overcoming complexity in TAVI: a patient-centered approach

One price, unlimited learning: Holiday PCR Publishing offer

18 Dec 2025

Celebrate the season with our exclusive Christmas offer! Choose any digital subscription - EuroIntervention and/or The PCR Textbook – for €85.

Holiday Special: Any digital subscription for just €85 from 18 to 22 December only!

TAVI - LIVE Case

11 Dec 2025 – From GulfPCR-GIM 2025

This educational session features a live case presentation from King Faisal Cardiac Center focusing on transcatheter aortic valve implantation (TAVI). It encompasses comprehensive patient evaluation, detailed imaging analysis, strategic procedural planning, and the execution of the TAVI procedure, providing an in-depth learning experience from a high-volume...

TAVI - LIVE Case

Beyond the horizon - Shaping the future of cardiology through meaningful innovation in structural heart and coronary - LIVE Case

11 Dec 2025 – From GulfPCR-GIM 2025

This session offers an in-depth exploration of the latest advancements in structural heart and coronary interventions. It covers expert insights on best-in-class TAVI practices, including pre-procedural imaging, sizing rationale, procedural tips, and post-procedural management. Attendees will also gain a comprehensive understanding of the novel Myval THV...

Beyond the horizon - Shaping the future of cardiology through meaningful innovation in structural heart and coronary

Innovation and teamwork in structural heart interventions

11 Dec 2025 – From GulfPCR-GIM 2025

This session explores innovations and collaborative approaches in structural heart interventions, focusing on aortic and mitral valve procedures. It addresses procedural indications, challenges, and the evolving roles of non-physician allied professionals. Interactive elements foster knowledge exchange and support the growth of expertise in the structural heart...

Challenging TAVI cases - Part 1

10 Dec 2025 – From GulfPCR-GIM 2025

Addressing complex TAVI cases, this session focuses on procedural challenges and advanced strategies to optimize safety and outcomes. Topics include high-risk valvuloplasty, management with prosthetic valves, and considerations in patients with valve thrombus.

Abstracts session 1

10 Dec 2025 – From GulfPCR-GIM 2025

This abstracts session presents contemporary research and clinical insights in interventional cardiology, covering topics such as colchicine therapy post-stenting, ranolazine use in chronic coronary syndrome, artificial intelligence applications in quantitative coronary analysis, and optimization techniques in transcatheter aortic valve implantation. It also explores novel predictors of...

Challenging Cases

10 Dec 2025 – From GulfPCR-GIM 2025

This session presents a series of challenging cardiology cases that span a spectrum of clinical scenarios, including innovative approaches to hypertrophic obstructive cardiomyopathy management, rare coronary artery anomalies, fibrous lesions, and unusual acute coronary syndromes. These case studies highlight diagnostic complexities and therapeutic strategies essential for...

Challenging Cases

Challenging cases from the East

10 Dec 2025 – From GulfPCR-GIM 2025

This session from Eastern cardiology centers addresses complex interventional challenges including recurrent left internal mammary artery (LIMA) failure, management of transcatheter aortic valve implantation (TAVI) complications, and treatment of heavily calcified coronary lesions. Through detailed case presentations and key learnings, it offers valuable insights into successful...

Challenging cases from the East

The importance of PPM in younger patients in TAVI valve choice

08 Dec 2025

Kristoffer Russell discusses prosthesis–patient mismatch (PPM), which can increase mortality, heart failure hospitalisations, and reduce functional recovery, especially in younger patients. While less common after TAVI than surgical valve replacement, studies show up to 30% of younger, low-risk TAVI patients still experience moderate or severe PPM,...

The importance of PPM in younger patients in TAVI valve choice

How are the 2025 ESC EACTS valvular guidelines going to impact my TAVI programme?

17 Dec 2025 – From PCR London Valves 2025

Bernard Prendergast and Fabien Praz discuss updates from the new ESC/EACTS guidelines on aortic stenosis. Key changes include expanding TAVI to patients aged 70 and older, supporting early intervention in asymptomatic patients, and providing guidance for bicuspid aortic valves. These updates emphasise shared decision-making, careful patient...

How are the 2025 ESC EACTS valvular guidelines going to impact my TAVI programme

New roads begin where old ones end: a TAVI case

08 Dec 2025

An 85-year-old woman presents with exertional dyspnea and angina, alongside severe paradoxical low-flow, low-gradient aortic stenosis, marked mitral and tricuspid valve disease, and two-vessel coronary artery disease. Frailty markers and hostile pelvic anatomy further complicate her profile.

How would your Heart Team approach this challenging case?

Norman Mangner

Author

Norman Mangner
Stephan Haussig

Author

Stephan Haussig
New roads begin where old ones end: a TAVI case

When the first TAVI fails: no panic, just planning

02 Dec 2025

An 81-year-old man with history of severe aortic stenosis previously treated with a balloon-expandable transcatheter valve was referred for progressive exertional dyspnea due to bioprosthetic valve degeneration.

How would you treat this patient?

Barbara Bellini

Author

Barbara Bellini
When the first TAVI fails: no panic, just planning

In what situation is emergency transcatheter valve intervention a valid alternative to surgery?

16 Nov 2025 – From PCR London Valves 2025

Azeem Latib and Giuseppe Tarantini discuss how transcatheter therapies are increasingly used to treat critically ill patients with severe valvular disease and cardiogenic shock—patients once considered untreatable. They highlight cases ranging from severe AS with ACS to acute papillary muscle rupture and acute severe regurgitation, showing...

In what situation is emergency transcatheter valve intervention a valid alternative to surgery?

PCR London Valves 2025: Best of Social Media Coverage

20 Nov 2025

This year’s coverage was built on innovative formats to support one clear strategy: sharing strong messages and high-quality education through well-prepared, creative content. The #PCRLV social media team was led by Pamela Gatto, and divided into 6 tracks: aortic, mitral, tricuspid, closure, imaging and nursing.

PCR London Valves 2025: Best of Social Media Coverage

Redo TAVI for transcatheter heart valve failure

18 Nov 2025 – From PCR London Valves 2025

This session addresses the critical considerations involved in re-do TAVI procedures for transcatheter heart valve failure. It guides through key decision-making processes, step-by-step CT analysis for procedural planning, and established protocols to effectively execute valve-in-valve interventions, enhancing outcomes in complex repeat valve therapies.

Redo TAVI for transcatheter heart valve failure

A new era for aortic regurgitation: how new guidelines and dedicated devices for AR will redefine treatment

18 Nov 2025 – From PCR London Valves 2025

This session examines the evolving treatment landscape for aortic regurgitation (AR) in light of new ESC guidelines and dedicated devices such as the JenaValve Trilogy System. It provides an in-depth look at refined diagnosis, optimized treatment strategies, and presents real-world data and clinical cases that highlight...

A new era for aortic regurgitation: how new guidelines and dedicated devices for AR will redefine treatment